Article · 2022
Editor-in-Chief
HARDIK CHANDASANA
Professor, Department of Pharmaceutics, University of Florida, USA
About
As published by the journal they serve.
Well experienced in conducting analytical DMPK activities like in vitro Plasma stability, Metabolic stability with liver microsomes and Hepatocytes, Reaction phenotyping, Plasma protein binding, CYP inhibition assays for IC 50 value, RBC Partitioning, Drug stability in SGF and SIF, Metabolite identification and other analytical studies such as solubility, chemical stability, logP, logD value measurement etc .
Preclinical formulation for PK studies.
Bioanalytical method development and validation ( Plasma, Tears, Vaginal fluids ,Tissues etc.)
Animal Handling Techniques.(Rat, Mice, Hamster and Rabbit).
Experience in preclinical (Mice, Rat, Hamster and Rabbit) and clinical (healthy volunteers) ADME/pharmacokinetic evaluation of NCEs/drugs and their formulations
Preclinical tissue distribution studies.
Drug-drug, herb-drug and food-drug interaction studies for suggesting benefits (as potential combination)/risks of the same in therapies.
Preclinical and clinical data analysis, modeling, biostatistics and IVIVC. Dose predictions and PBPK modeling for human pharmacokinetic prediction. Conduction and data analysis of bioavailability, bioequivalence and food effect studies.
Microdialysis technique to determine free drug concentration
Research interests
Journals they serve
The seats these journals name them in.
- Journal of Drug Metabolism & ToxicologyEditor-in-Chief
Articles we hold
Articles in the journals they serve whose byline carries this name.
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.